202.00
-1.80
(-0.88%)
At close: January 14 at 5:35:14 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 13 | 13 |
| Avg. Estimate | 1.08 | 0 | 3.41 | 4.25 |
| Low Estimate | 0.89 | 0 | 2.84 | 3.98 |
| High Estimate | 1.38 | 0 | 3.85 | 4.67 |
| Year Ago EPS | 0.72 | 0.86 | 4.19 | 3.41 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | -- | 13 | 12 |
| Avg. Estimate | 722.22M | -- | 2.77B | 2.99B |
| Low Estimate | 706.5M | -- | 2.7B | 2.91B |
| High Estimate | 732.74M | -- | 2.83B | 3.11B |
| Year Ago Sales | 706.8M | -- | 2.78B | 2.77B |
| Sales Growth (year/est) | 2.18% | -- | -0.36% | 8.29% |
Earnings History
| Currency in EUR | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.87 | 0.94 | 1.02 | 0.84 |
| EPS Actual | 0.72 | 0.86 | 0.85 | 0.76 |
| Difference | -0.15 | -0.08 | -0.17 | -0.08 |
| Surprise % | -17.70% | -8.48% | -16.72% | -9.14% |
EPS Trend
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.08 | 0 | 3.41 | 4.25 |
| 7 Days Ago | 1.06 | 0 | 3.4 | 4.28 |
| 30 Days Ago | 1.06 | 0 | 3.4 | 4.29 |
| 60 Days Ago | 1.06 | 0 | 3.44 | 4.33 |
| 90 Days Ago | 1.06 | 0 | 3.61 | 4.44 |
EPS Revisions
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | -- | 2 | 1 |
| Up Last 30 Days | 2 | -- | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DIM.PA | 50.46% | -- | -18.61% | 24.75% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Downgrade | Societe Generale: Buy to Hold | 10/1/2021 |
Related Tickers
SRT.DE Sartorius Aktiengesellschaft
190.20
-1.35%
SRT3.DE Sartorius Aktiengesellschaft
236.60
-2.75%
1SXP.DE SCHOTT Pharma AG & Co. KGaA
24.38
-2.56%
ALCJ.PA Crossject Société Anonyme
2.1450
-1.15%
YPSN.SW Ypsomed Holding AG
324.50
-1.96%
STMN.SW Straumann Holding AG
118.50
+1.59%
STVN Stevanato Group S.p.A.
21.65
-1.23%
BONEXs.XC
COLOBc.XC
7749.T Medikit Co.,Ltd.
2,617.00
+0.23%